InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Robertson Jenny. Director active across 1 company, notably Lexeo Therapeutics, Inc.. In total, 8 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €17k. Activity tracked since 5 January 2024. The latest transaction was disclosed on 18 November 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Robertson Jenny is a declarant linked to Lexeo Therapeutics, Inc., where she is Chief Legal Officer. She has 8 filings in total, and across the 8 most recent sampled filings between 2024-01-09 and 2025-11-20, sales total 16724 EUR and the modal transaction nature is Cession.